Autonomix Medical, Inc. (NASDAQ:AMIX – Get Free Report) saw a significant increase in short interest during the month of December. As of December 15th, there was short interest totalling 109,400 shares, an increase of 198.9% from the November 30th total of 36,600 shares. Currently, 9.2% of the shares of the company are short sold. Based on an average daily trading volume, of 534,900 shares, the days-to-cover ratio is currently 0.2 days.
Analysts Set New Price Targets
Separately, LADENBURG THALM/SH SH assumed coverage on shares of Autonomix Medical in a research report on Tuesday, September 3rd. They set a “buy” rating and a $28.00 target price on the stock.
View Our Latest Report on AMIX
Autonomix Medical Price Performance
About Autonomix Medical
Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.
Further Reading
- Five stocks we like better than Autonomix Medical
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- What Are Dividend Champions? How to Invest in the Champions
- Top 3 ETFs to Hedge Against Inflation in 2025
- What Are the FAANG Stocks and Are They Good Investments?
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for Autonomix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Autonomix Medical and related companies with MarketBeat.com's FREE daily email newsletter.